Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT02796118
Eligibility Criteria:
Inclusion Criteria:
* Body weight: ≥50.0 kg and \<85.0 kg
* Body mass index (BMI): ≥17.6 and \<26.4 kg/m2
Exclusion Criteria:
* Subjects with a complication of any diseases
* Subjects with a history of hepatic disease
* Subjects with a history of heart disease
* Subjects with a history of respiratory disease
* Subjects with a history of alimentary disease
* Subjects with a history of renal disease
* Subjects with a history of cerebrovascular disorder
* Subjects with a history of malignant tumor
* Subjects with a history of drug allergies or allergies disorders excluding pollinosis
* Subjects with a history of drug dependency or alcohol dependence syndrome
* Subjects who developed genital herpes or herpes zoster within 90 days before the initial dosing
* Subjects who do not meet any of the criteria for laboratory tests
* Subjects who received medications within 14 days before the initial dosing.
* Subjects who received any investigational drugs in other clinical trials or post-marketing studies within 120 days before screening or the initial dosing
* Excessive alcohol drinking or smoking habit
* Subjects who previously received administration of ASP2151 (including placebo)
* Abnormalities detected on an ophthalmological examination
* Subjects who deviate from the normal range of standard 12-lead ECG at screening
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
20 Years
Maximum Age:
79 Years
Study:
NCT02796118
Study Brief:
Protocol Section:
NCT02796118